0001181431-14-032640.txt : 20140925 0001181431-14-032640.hdr.sgml : 20140925 20140925203448 ACCESSION NUMBER: 0001181431-14-032640 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140924 FILED AS OF DATE: 20140925 DATE AS OF CHANGE: 20140925 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Sagent Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001369786 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE BUSINESS ADDRESS: STREET 1: 1901 NORTH ROSELLE ROAD, SUITE 700 CITY: SCHAUMBURG STATE: IL ZIP: 60195 BUSINESS PHONE: 847-908-1604 MAIL ADDRESS: STREET 1: 1901 NORTH ROSELLE ROAD, SUITE 700 CITY: SCHAUMBURG STATE: IL ZIP: 60195 FORMER COMPANY: FORMER CONFORMED NAME: Sagent Holding Co. DATE OF NAME CHANGE: 20090529 FORMER COMPANY: FORMER CONFORMED NAME: NHS PHARMACEUTICALS DATE OF NAME CHANGE: 20060720 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FLANAGAN ROBERT J CENTRAL INDEX KEY: 0001251512 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35144 FILM NUMBER: 141121744 MAIL ADDRESS: STREET 1: C/O SAGENT PHARMACEUTICALS, INC. STREET 2: 1901 NORTH ROSELLE ROAD, SUITE 700 CITY: SCHAUMBURG STATE: IL ZIP: 60195 4 1 rrd416690.xml X0306 4 2014-09-24 0 0001369786 Sagent Pharmaceuticals, Inc. SGNT 0001251512 FLANAGAN ROBERT J C/O SAGENT PHARMACEUTICALS, INC. 1901 NORTH ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195 1 0 0 0 Common Stock 6996 D Common Stock 2000 I See Footnote Common Stock 2014-09-24 4 S 0 8000 30.30 D 465770 I See Footnote Common Stock 2014-09-25 4 S 0 8000 29.72 D 457770 I See Footnote The shares reported are held by Flanagan Family Limited Partnership. Mr. Flanagan is a managing member of E.O. Flanagan LLC, the general partner of Flanagan Family Limited Partnership. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.89 to $30.52, inclusive. This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 19, 2014. The shares reported are held of record by CNF Investments II, LLC. Voting and investment decisions with respect to all shares held by CNF Investments II, LLC are exercised by its managing member, Mr. Flanagan. Accordingly, Mr. Flanagan may be deemed the beneficial owner of such shares. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.55 to $30.22, inclusive. This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 19, 2014. /s/ Robert J. Flanagan 2014-09-25